middle.news
Vitasora Advances $11M Placement, Eyes Breakeven by H2 FY2026
7:02pm on Tuesday 8th of July, 2025 AEST
•
Healthcare
Read Story
Vitasora Advances $11M Placement, Eyes Breakeven by H2 FY2026
7:02pm on Tuesday 8th of July, 2025 AEST
Key Points
First tranche of $3.72 million settled with 124 million shares issued
Second tranche to follow post-Extraordinary General Meeting in August
Funds earmarked for clinical operations, technology upgrades, and sales expansion
Capital raise supports path to cash flow breakeven in H2 FY2026
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Vitasora Health (ASX:VHL)
OPEN ARTICLE